US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

Wockhardt's Aspart insulin injection is an indigenously developed product, underscoring the company's end to end capabilities ...

Wockhardt, a global pharmaceutical and biotechnology major, announces the filing of its fast-acting insulin analog, Aspart injection, with the Drugs Controller General of India.

In addition to the publications reviewed, evidence was also found to support the use of insulin aspart in combination therapy and areas currently ‘off-label´ such as pregnancy and/or ...

The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

and Novo's Ryzodeg (insulin degludec / insulin aspart), respectively, in type 2 diabetes trials. In patients with poor glycemic control on oral antidiabetic drugs, Gan & Lee's once-weekly GZR4 ...

Ryzodeg (insulin degludec / insulin aspart) contains the new-generation once-daily basal insulin degludec in a soluble formulation with insulin aspart. Both of these products will be available in ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...

According to the American Society of Health-System Pharmacists' database, insulin aspart injection, another daily medication, has been in short supply since last November. “This is about the ...

WASHINGTON, Oct 30 (Reuters) - Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a major accomplishment of the Biden ...

A 25-year-old woman with type 1 diabetes has been able to stop taking insulin after a groundbreaking stem cell treatment. This is the first human trial of the procedure, and while it’s too soon ...